Evidence-based·Last reviewed May 30, 2026·How we grade evidence

Milk Thistle

BotanicalMagnesium dihydroxideBest with a meal

Useful mainly for adults with liver disease risk factors (fatty liver, alcohol use, hepatotoxic drug exposure) seeking hepatoprotective support.

Quick decision guide

May help most

Adults with liver disease risk factors (fatty liver, alcohol use, hepatotoxic drug exposure) seeking hepatoprotective support

Common dosing range

200–600 mg/day of standardized silymarin extract

When to expect effects

8–12 weeks for liver enzyme changes

Watch out for

Inhibits CYP2C9 and CYP3A4 — can alter levels of statins, warfarin, and other medications

What is it

Milk thistle (Silybum marianum) is a flowering plant native to the Mediterranean region, cultivated since ancient Greek and Roman times. Its seeds contain a complex of flavonolignans collectively called silymarin, which is the bioactive standardized extract used for liver-related applications.

Is it worth it for you?

Use this as a quick fit check, not a diagnosis.

Worth considering if

You have NAFLD or elevated liver enzymes from metabolic causes and want botanical adjunct support
You are taking a hepatotoxic medication long-term and want liver-protective support
You have a history of excessive alcohol use and are working to reduce it

Probably skip if

You expect it to substitute for medical treatment of cirrhosis or viral hepatitis
You have allergies to ragweed, daisies, or chrysanthemums (Asteraceae family)
You take warfarin, statins, or other narrow-therapeutic-index drugs without pharmacist review

Evidence at a glance

non-alcoholic fatty liver disease (NAFLD)

Limited Evidence
Effect
Modest ALT and AST reductions; liver fat reduction in some trials
Best fit
Adults with NAFLD confirmed by imaging or biopsy
Time
8–24 weeks

drug-induced liver injury prevention

Limited Evidence
Effect
Modest attenuation of liver enzyme elevation in some drug-exposed populations
Best fit
Adults taking long-term hepatotoxic medications (antituberculars, antifungals, antipsychotics)
Time
4–12 weeks

type 2 diabetes glycemic control

Limited Evidence
Effect
Modest HbA1c and fasting glucose reductions in some meta-analyses
Best fit
Adults with type 2 diabetes and concurrent liver disease or elevated liver enzymes
Time
12–24 weeks

Evidence for 3 uses

AI-assisted evidence assessment — talk to your doctor before relying on any single supplement.

non-alcoholic fatty liver disease (NAFLD)

Biomarker support
Limited Evidence

Multiple RCTs and several meta-analyses report that silymarin reduces serum ALT and AST in NAFLD patients compared to placebo. Some trials report reduced liver fat on imaging. Effect sizes are modest and trials vary in quality. Silymarin does not address the underlying metabolic drivers of NAFLD; lifestyle changes remain primary.

Effect size
Modest ALT and AST reductions; liver fat reduction in some trials
Time to effect
8–24 weeks
Best fit
Adults with NAFLD confirmed by imaging or biopsy

Bottom line: Modest liver enzyme biomarker benefit in NAFLD; use as an adjunct to weight loss and dietary change, not a substitute.

drug-induced liver injury prevention

Biomarker support
Limited Evidence

Small RCTs in patients taking hepatotoxic drugs (antituberculars, antifungals, cancer chemotherapy) show silymarin may attenuate rises in liver enzymes. Evidence quality varies and no trial has adequately powered for clinical liver disease endpoints. Mechanism (membrane stabilization, antioxidant effects) is biologically plausible.

Effect size
Modest attenuation of liver enzyme elevation in some drug-exposed populations
Time to effect
4–12 weeks
Best fit
Adults taking long-term hepatotoxic medications (antituberculars, antifungals, antipsychotics)

Bottom line: Biologically plausible and modest evidence, but clinical endpoint data are lacking; discuss with prescriber before using alongside hepatotoxic medications.

type 2 diabetes glycemic control

Biomarker support
Limited Evidence

Several meta-analyses of RCTs in type 2 diabetes report statistically significant reductions in fasting glucose and HbA1c with silymarin (200600 mg/day). The mechanism is thought to involve improved insulin sensitivity via AMPK and reduced oxidative stress in hepatocytes. Effect sizes are modest and studies are largely in populations with concurrent hepatic disease.

Effect size
Modest HbA1c and fasting glucose reductions in some meta-analyses
Time to effect
12–24 weeks
Best fit
Adults with type 2 diabetes and concurrent liver disease or elevated liver enzymes

Bottom line: Secondary glycemic benefit possible in diabetics with liver disease; not a primary diabetes intervention.

How it works

Silymarin is actually a complex of related compounds, the most active of which are silybin (also called silibinin), isosilybin, silychristin, and silydianin. Silybin alone accounts for roughly 60 to 70 percent of silymarin's activity. The proposed mechanisms include direct antioxidant activity in hepatocytes, stabilization of liver cell membranes against toxins, stimulation of hepatic protein synthesis and regeneration, and inhibition of fibrosis pathways implicated in chronic liver disease. Silymarin has been used most extensively for treatment of Amanita phalloides (death cap mushroom) poisoning, where intravenous silybin (Legalon SIL) is an established part of treatment protocols in many European countries. For chronic liver conditions (cirrhosis, viral hepatitis, NAFLD, drug-induced liver injury), oral silymarin shows more variable and often modest effects in clinical trials. Bioavailability of standard silymarin is poor; phytosomal formulations (silymarin bound to phosphatidylcholine, sold as Siliphos or similar) substantially improve absorption.

How to take it

1. Typical dose
200–300 mg twice daily of standardized silymarin (70–80% silymarin content)
2. Higher studied dose
420–800 mg/day in chronic liver disease trials
3. Timing
With meals — improves absorption of the fat-soluble flavonolignans
4. With food
With food; fat-containing meal further aids absorption
5. Split dosing
Split dose twice daily preferred over single large dose for steadier plasma levels
6. How long to try
8–12 weeks minimum; effects on liver enzymes may take several months

What to track

Liver enzyme levels (ALT, AST) via bloodwork
Fatigue and energy levels
GI tolerance
Any signs of allergic reaction, especially in Asteraceae-sensitive individuals

4 commercial forms

Compare the main delivery options and what they’re best suited for.

Standardized silymarin extract (80 percent flavonolignans)

Most common consumer form. 200 to 600 mg/day typical.

Standardized to silymarin content; oral bioavailability of silybin is poor.

Siliphos (silybin phytosome)

Most absorbable oral form. Lower doses produce equivalent effects.

Silybin complexed with phosphatidylcholine; 5 to 10 times higher plasma silybin than standard.

Whole milk thistle seed

Traditional whole-food form. Used as 1 to 2 tsp ground seeds per day.

Lowest silymarin content; high fiber.

IV silybin (Legalon SIL)

Used for Amanita mushroom poisoning. Not consumer-available.

Complete delivery; hospital use only.

Safety

Know the common side effects, key cautions, and who should avoid it.

Common side effects

Mild GI upset (nausea, gas, diarrhea)HeadacheRare allergic reactions

Serious risks

Who should avoid it

Pregnancy & breastfeeding

Limited safety data — some traditional use exists, but consult a clinician before use during pregnancy or breastfeeding.

Interactions

WarfarinModerate

CYP2C9 inhibition may raise warfarin levels and increase bleeding risk

Statins (simvastatin, lovastatin)Moderate

CYP3A4 inhibition can raise statin levels; increased myopathy risk

Antidiabetic medicationsModerate

Additive glucose lowering; monitor blood glucose

Antipsychotics (haloperidol, risperidone)Minor

CYP interactions may alter antipsychotic blood levels

Hormone-sensitive cancer treatmentsMinor

Theoretical estrogenic receptor activity; discuss with oncologist

Documented interactions

Protocols featuring Milk Thistle

Evidence-backed routines where Milk Thistle plays a role.

Food sources

Milk thistle seeds (1 tsp ground)

Amount
minimal silymarin content; concentrated extracts preferred
%DV

Choosing a product

What to look for on the label — and what to be skeptical of.

Look for

Standardized to 70–80% silymarin content
Phytosomal form (silymarin-phosphatidylcholine complex) if superior absorption is desired
Clear mg of silymarin per dose, not just total herb weight

Be skeptical of

"Detoxifies your liver" — the liver detoxifies itself; silymarin supports hepatocyte health, not detox
"Treats liver disease" — a supplement claim, not a medical claim; disease management requires medical care
"Safe with all medications" — significant CYP interactions exist

Frequently asked questions

Will milk thistle protect my liver from alcohol?

No reliable evidence supports milk thistle as a pre-drinking 'liver protector.' Trials in active alcoholic liver disease show mixed and modest results. Stopping or reducing drinking is dramatically more effective than any supplement.

Is milk thistle the same as silymarin?

Silymarin is the active flavonolignan complex extracted from milk thistle seeds, accounting for most of its effects. Standardized milk thistle supplements typically contain 80 percent silymarin. Silybin is the most active single component within silymarin.

How long until milk thistle works?

Effects on liver enzymes typically build over 8 to 12 weeks. Acute single-dose effects are minimal. Don't expect to feel different after a few days.

Can I take milk thistle with my medications?

Coordinate with your prescriber. Milk thistle affects CYP450 enzymes (especially CYP3A4 and CYP2C9), which metabolize many medications. Most common drugs are not meaningfully affected, but check with your pharmacist.

Is the phytosomal version worth the extra cost?

For people with serious liver concerns, the substantially better absorption of phytosomal silymarin (Siliphos) may justify the cost. For general liver support, standard silymarin extract is reasonable and well-studied.

References by claim

non-alcoholic fatty liver disease (NAFLD)

Li et al., 2024PubMed (2024) link

Shahsavari et al., 2025PMC (2025) link

drug-induced liver injury prevention

Asgarshirazi et al., 2017PubMed (2017) link

Luangchosiri et al., 2015PMC (2015) link

type 2 diabetes glycemic control

Voroneanu et al., 2016PMC (2016) link

Hadi et al., 2018PubMed (2018) link

Safety

Memorial Sloan Kettering — Milk ThistleMSKCC About Herbs link

Track Milk Thistle with Pilora

Set up dose reminders, check interactions, and join the community in the Pilora iPhone app.

Coming to App Store
Evidence-based·Last reviewed May 30, 2026·Evidence current as of May 30, 2026·How we grade evidence

Disclaimer: These statements have not been evaluated by the FDA. This page is educational, not a substitute for personalized medical advice. Evidence grades are AI-assisted assessments — talk to your doctor before starting any new supplement, especially if you’re pregnant, breastfeeding, on medications, or managing a chronic condition.